Literature DB >> 29633855

A novel role of HIF-1α/PROX-1/LYVE-1 axis on tissue regeneration after renal ischaemia/reperfusion in mice.

Fanwei Meng1.   

Abstract

Context: Renal ischaemia reperfusion (I/R) is a common clinical condition with a high morbidity and mortality rate. To date, I/R-induced renal injury remains an ineffective treatment. Objective: We hypothesis that angiogenesis and lymphangiogenesis markers, prospero homeobox-1 (PROX-1) and lymphatic endothelial hyaluronan receptor-1 (LYVE-1), are critical during I/R. Material and methods: Kunming mice were subjected to I/R and observed for the following eight consecutive days. Pathology analysis and protein distribution were detected by H&E staining, immunohistochemistry and immunofluorescence confocal analysis.
Results: After I/R treatment, renal pathology was changed. HIF-1α was induced in the early stage and colocalisation with PROX-1 mainly in the renal tubular region, whereas PROX-1 and LYVE-1 were colocalised in the glomerulus of the endothelial region. Conclusions: In this study, we revealed HIF-1α/PROX-1/LVYE-1 axis dynamic changes in different regions after I/R and demonstrated for the first time it activates during I/R repair.

Entities:  

Keywords:  HIF-1α; I/R; LVYE-1; PROX-1; renal repair

Mesh:

Substances:

Year:  2018        PMID: 29633855     DOI: 10.1080/13813455.2018.1459728

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  2 in total

1.  RAF1 promotes lymphatic metastasis of hypopharyngeal carcinoma via regulating LAGE1: an experimental research.

Authors:  Min Pan; Tao Lu; Dan Yu; Chuan Liu; Zhihai Wang; Yanshi Li; Guohua Hu
Journal:  J Transl Med       Date:  2022-06-06       Impact factor: 8.440

2.  Serum sLYVE-1 is not associated with coronary disease but with renal dysfunction: a retrospective study.

Authors:  Daopeng Dai; Chunkai Huang; Jinwei Ni; Zhenbin Zhu; Hui Han; Jinzhou Zhu; Ruiyan Zhang
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.